icometrix is a Belgian healthtech company that develops AI-powered software for brain imaging. Its main product, icobrain, analyzes MRI and CT scans to help clinicians diagnose and monitor neurological conditions such as multiple sclerosis, Alzheimer’s, and strokes. The company also offers icobrain ARIA, an FDA-cleared solution for detecting amyloid-related abnormalities in Alzheimer’s treatments, and icompanion, a platform for patients to track symptoms and treatments. Icometrix collaborates globally with clinics and pharmaceutical companies, aiming to improve care for neurological disorders through AI.